Senior insider sale
Chief Medical Officer at BIOAGE LABS, INC. — senior position signals high conviction
$1.15M
101.76K shares
What this filing means
RUBIN PAUL D plans to sell 101.76K shares of BIOAGE LABS, INC. valued at approximately $1.15M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 2/2/2026ACC: 0001959173-26-000500
Officer· Chief Medical Officer
Since Mar 2026
101.76K
Shares to sell
$1.15M
Approx. market value
7.43K
Acquired (3 months)
1
Planned
3 completed
Securities Acquired — Last 3 Months2
Option Granted - 05/29/2022
Cash
2/2/2026
2KOption Granted - 07/01/2020
Cash
2/2/2026
5.43KTotal acquired7.43K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
2/2/2026 | Option Granted - 05/29/2022 Cash | 2K | — |
2/2/2026 | Option Granted - 07/01/2020 Cash | 5.43K | — |
| Total | 7.43K | ||
Planned & Completed Dispositions4
Completed
—Completed
Units to sell
7.43K
Market value
$95.5K
1/2/2026
—Completed
Units to sell
18K
Market value
$216.0K
12/9/2025
—Completed
Units to sell
68.90K
Market value
$701.9K
12/4/2025
Planned — Approximate Date
NASDAQPlanned
Units to sell
7.43K
Market value
$139.4K
2/2/2026
Total
Units
101.76K
Value
$1.15M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
1/2/2026 | 7.43K | $95.5K | — | Completed |
12/9/2025 | 18K | $216.0K | — | Completed |
12/4/2025 | 68.90K | $701.9K | — | Completed |
| Planned — Approximate Date | ||||
2/2/2026 | 7.43K | $139.4K | NASDAQ | Planned |
| Total | 101.76K | $1.15M | ||